Patient advocacy platform Baba has made its public debut with $6.5 million in seed led by General Catalyst, the company disclosed last week.

Amid rising healthcare costs and shrinking government coverage, two major patient assistance charities have announced a strategic merger they say will help ramp up aid.  | The Patient Advocate ...

The Alliance for Patient Access, or AfPA, is celebrating two decades of clinician-led advocacy that has helped shape health policy affecting patient access, treatment choice and the clinician-patient ...

Patient Advocate Foundation and PAN Foundation today announced a strategic merger to create the nation's most comprehensive nonprofit dedicated to helping patients navigate, access, and afford care, ...

The Patient Advocate Foundation and the PAN Foundation have announced a strategic merger to create the nation’s most ...

As Hashimoto’s Disease Awareness Day continues to grow in national recognition, Clayman Thyroid Center remains committed to improving thyroid health literacy and ensuring that individuals living with ...

Cancer treatment is hard enough without bureaucratic and policy hurdles, two doctors argue. Better advocacy is necessary.

A few weeks ago, the World Health Organization observed “World Patient Safety Day 2023” with this theme: “Elevate the voice of patients!” Only by engaging patients, families and caregivers, the WHO ...

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here, or ...

Add Yahoo as a preferred source to see more of our stories on Google. Receiving a breast cancer diagnosis can be a life-altering experience, and it can also feel like you’re the only one going through ...

When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare respiratory disease, you question why researchers and resource-backed pharma cannot bring a ...

Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, announced ...